Beovu 120 mg/ml solution for injection in pre-filled syringe

${arrow_up}$ Back to top

Beovu 120 mg/ml solution for injection in pre-filled syringe ${equilateral_black_triangle}$

Active Ingredient:

brolucizumab

Company:

Novartis Pharmaceuticals UK Ltd See contact details

ATC code:

S01LA06

About Medicine

${medical_services}$

Prescription only medicine

My Account Area

${arrow_down}$

Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs Audio/Video Live Chat HCP Med Info

${arrow_left}$

${arrow_right}$

Audio Guide to Beovu - Click on the PLAY button to listen, or right click to save the audio file. To view or download a text version see the 'Risk Materials' tab.

Beovu Patient Guide to Therapy - Audio Version
This audio has been produced by Novartis Pharmaceutical Limited. Your guide to therapy with Beovu (brolucizumab) – for the treatment of neovascular (wet) age-related macular degeneration (AMD).

Beovu Patient Guide to Therapy - for patients with visual impairment due to DMO
This audio has been produced by Novartis Pharmaceutical Limited. Your guide to therapy with Beovu (brolucizumab) – for the treatment of patients with visual impairment due to Diabetic Macular Oedema (DMO).